Health Canada’s Anti-Drug Strategy Initiatives (ADSI) program provides $22.8M in annual funding to facilitate the development of solutions to substance abuse problems along the continuum of care from health promotion and prevention to treatment.

ADSI reflects the merger of the former Drug Strategy Community Initiatives Fund (DSCIF) and the Drug Treatment Funding Program (DTFP). Projects funded under these two previous funding programs will continue until the end of their respective agreements.

ADSI continues to support the National Anti-Drug Strategy Prevention and Treatment Action Plans’ mandates by funding initiatives to:

• Prevent substance abuse issues and related problem;
• Facilitate improvements to the treatment continuum of care; and
• Improve awareness, knowledge and skills of key stakeholders.

Current treatment projects support sustainable improvement in the quality and organization of Canada’s substance abuse treatment systems. This helps provinces, territories and other organizations address both illicit and prescription drug abuse and provide evidence-based programs to support people on the road to recovery. Find out more about the national, provincial, and territorial projects below.

Overall expected results for Anti-Drug Strategy Initiatives include:

• Uptake of evidence-informed information on substance abuse by relevant partners;
• Reduced risk-taking behaviours associated with substance abuse among target populations;
• Increased efficiency and effectiveness of treatment and prevention programs, services and systems; and
• Increased awareness and understanding among target populations of substance abuse and its negative consequences.